RECURRENT CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Clinical trials for RECURRENT CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new RECURRENT CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE trials appear
Sign up with your email to follow new studies for RECURRENT CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on tough blood cancers in new trial
Disease control Recruiting nowThis early-phase trial tests a new type of CAR T-cell therapy for people with certain blood cancers (like lymphoma, leukemia) that have returned or not responded to standard treatments. The therapy uses a patient's own immune cells, modified in a lab to target three cancer marker…
Matched conditions: RECURRENT CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Engineered immune cells take aim at returning leukemia
Disease control Recruiting nowThis early-stage study tests a new treatment for children and adults with acute leukemia that has come back or not responded after a donor stem cell transplant. The treatment uses the patient's own immune cells (T cells) that are modified in a lab to recognize and attack a protei…
Matched conditions: RECURRENT CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:40 UTC